tm logo
Trademark Search
MULTICOLOURED GEOMETRIC SHAPES IN THE CONFIGURATION OF A TRIANGLE
MULTICOLOURED GEOMETRIC SHAPES IN THE CONFIGURATION OF A TRIANGLE
REGISTERED

on 07 Sep 2022

Last Applicant/ Owned by

H. LUNDBECK A/S

Ottiliavej 9DK-2500 Valby

DK

Serial Number

2050555 filed on 14th May 2020

Registration Number

TMA1141381 registered on 07th Sep 2022

Registration expiry Date

14th May 2030

Correspondent Address

1100-150 York StreetToronto

ONTARIO

CA

M5H3S5

MULTICOLOURED GEOMETRIC SHAPES IN THE CONFIGURATION OF A TRIANGLE

Vienna Information


26 . 3 . 4

Several triangles, juxtaposed, joined or intersectingPlusieurs triangles, juxtaposés, accolés ou se coupant

26 . 3 . 5

Triangles pointing downwardsTriangles avec la pointe en bas

26 . 3 . 7

Triangular figures with one or more truncated or rounded anglesFigures triangulaires à un ou plusieurs angles coupés ou arrondis

26 . 3 . 24

Triangles with dark surfaces or parts of surfacesTriangles avec surface ou partie de la surface foncée

26 . 7 . 15

Triangles or lines forming an angle with one or more quadrilateralsTriangles ou lignes formant un angle avec un ou plusieurs quadrilatères

27 . 5 . 1

Letters presenting a special form of writingLettres présentant un graphisme spécial

27 . 5 . 21

One letterUne lettre

27 . 1 . 1

Letters or numerals forming geometrical figures, written or typographical matter in perspectiveLettres ou chiffres formant des figures géométriques, inscriptions en perspective

27 . 1 . 5

Letters or numerals forming a triangle (surface or periphery)Lettres ou chiffres formant un triangle (surface ou pourtour)

29 . 1 . 1

Red, pink, orangeRouge, rose, orangé

29 . 1 . 4

BlueBleu

Trademark usage description

vaccines for humans; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting Read More

Classification Information


Class [005]
Vaccines for humans; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system, namely central nervous system infections, brain diseases, central nervous system movement disorders, spinal cord diseases; pharmaceutical preparations and substances acting on the central nervous system, namely central nervous system infections, brain diseases, central nervous system movement disorders, spinal cord diseases; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases, namely Alzheimer's, Huntington's Disease, cerebral palsy; pharmaceutical preparations and substances for the prevention and treatment of dementia, Alzheimer's disease and disorder, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disease and disorder, insomnia, Parkinson's disease and disorder, falls, movement disorders and diseases, tremor, schizophrenia, bipolar disorder and disease, mania, ADHD, PTSD, agitation, aggression, autism, melancholy, OCD, Tourette's syndrome, PSP, restlessness, akathisia, fatigue, somnolence, nausea, cancer, migraine, headaches, pain, alcoholism and dependency; pharmaceutical preparations and substances used for the prevention, management and treatment of headaches, migraines, pain, immune diseases and disorders, namely autoimmune diseases, immunologic deficiency syndromes; pharmaceutical preparations and substances for the prevention and treatment of dementia, Alzheimer's disorder and disease, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disorder and disease, insomnia, Parkinson's disorder and disease, falls, movement disorders and diseases, dyskinesia, poor or absent motor functions, tremor, schizophrenia, bipolar disorder and disease, mania, ADHD, PTSD, agitation, aggression, autism, melancholy, OCD, Tourette's syndrome, progressive supranuclear palsy (PSP), restlessness, akathisia, fatigue, somnolence, nausea, cancer, alcoholism and dependency; preparations, substances, reagents and agents for diagnostic and medical purposes, namely medical diagnostic reagents


Classification kind code

11

Mark Details


Serial Number

2050555

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 22
on 23rd Aug 2021
Search Recorded
Submitted for opposition 20
on 23rd Aug 2021
Examiner's First Report
Submitted for opposition 223
on 23rd Aug 2021
Total Provisional Refusal
Submitted for opposition 256
on 12th Jul 2021
Notification of Possible Opposition Sent
Submitted for opposition 48
on 16th Oct 2020
Agent Changed
Submitted for opposition 257
on 10th Sep 2020
Designation Notification - Madrid Protocol
Submitted for opposition 31
on 10th Sep 2020
Formalized
Submitted for opposition 1
on 09th Sep 2020
Created
Submitted for opposition 30
on 14th May 2020
Filed
Submitted for opposition 228
on 14th May 2020
International Registration